Affiliation:
1. Institute of Theoretical and Experimental Biophysics Russian Academy of Sciences Pushchino Moscow Region 142290 Russia
2. Institute of Cell Biophysics, Pushchino Scientific Center for Biological Research Federal Research Center of the Russian Academy of Sciences Pushchino Moscow Region 142290 Russia
Abstract
AbstractMetformin (1,1‐dimethylbiguanidine hydrochloride) (MF) is a drug that has long been in use for the treatment of type 2 diabetes mellitus and recently is coming into use in the radiation therapy of cancer and other conditions. Exposure to ionizing radiation disturbs the redox homeostasis of cells and causes damage to proteins, membranes, and mitochondria, destroying a number of biological processes. After irradiation, MF activates cellular antioxidant and repair systems by signaling to eliminate the harmful consequences of disruption of redox homeostasis. The use of MF in the treatment of the negative effects of irradiation has great potential in medical patients after radiotherapy and in victims of nuclear accidents or radiologic terrorism.
Subject
Pharmacology (medical),Pharmacology